Timothy S. Fuller, MD


Areas of Focus  |  Ocular Oncology, Medical Retina


Office Locations  |  Dallas Main, Athens


Certification  |  American Board of Ophthalmology


Languages Spoken  |  English, Spanish

“While I have a mother, father and brother in the medical field, working as an interpreter in a charity clinic and seeing the human side of medicine is what truly drew me to become a physician. I enjoy helping patients make sense of what is often a misunderstood disease, and hopefully offer a better quality of life to patients, especially those suffering from eye cancer.”

Fellowship


Ocular Oncology
Wills Eye Hospital
Philadelphia, Pennsylvania

Medical Retina
Texas Retina Associates
Dallas, Texas

Residency


Ophthalmology
University of Texas at Houston
Houston, Texas

Internship


University of Texas at Houston
Houston, Texas

Medical School


University of Texas at Houston
Houston, Texas

  • American Society of Retina Specialists
  • American Academy of Ophthalmology
  • Collaborative Ocular Oncology Group
  • Texas Medical Association
  • Dallas County Medical Society
  • Dallas Academy of Ophthalmology
  • Principal Investigator – Aura Biosciences, Inc. – AU-011-301 – A Phase III Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects with Primary Indeterminate Lesions or Small Choroidal Melanoma, 2023
  • Principal Investigator – RecensMedical – COOL-3s: A Randomized, Double-Masked, Controlled Trial Studying the Use of Rapid Cooling Anesthesia as Local Anesthesia for Patients Receiving Intravitreal Injections, 2023
  • Principal Investigator – Aura Biosciences, Inc. – AU-011-402 Case-Control Study – Visual Outcomes in Patients Treated with AU-011 or Plaque Radiotherapy for IL/CM, 2022
  • Sub-Investigator – REGENXBIO –RGX-314-3101 Ascent – Phase III –Gene Therapy nAMD, 2022
  • Principal Investigator – Aura Biosciences, Inc. – AU-011-401 Registry – Registry of Patients with Indeterminate and Small Choroidal Melanoma, 2021
  • Sub-Investigator – RecensMedical, Inc. – COOL-3 – Phase III – Medical Device; Rapid Cooling Anesthesia, 2021
  • Sub-Investigator – REGENXBIO – RGX-314-2104 Atmosphere – Phase IIb/III – Gene Therapy nAMD, 2021
  • Sub-Investigator – REGENXBIO – RGX-314-2103 Bioreactor – Phase II – Gene Therapy nAMD, 2021
  • Sub-Investigator – F. Hoffman-La Roche, Ltd. – BP41783 Longitude – Phase IV – Biomarker Study Anti-VEGF, nAMD, and DME, 2021
  • Sub-Investigator – Gyroscope Therapeutics, Ltd. – GT005-02 Explore (Surgical Study) – Phase II – Gene Therapy Dry AMD, 2021
  • Fuller TS, Shields CL. Choroidal nevus growth over 13 years: Is it a problem? Retina Today. 2017 January/February.
  •  Shields CL, Sioufi K, Fuller TS, Higgins T, Ferenczy SR, Shields, JA. Which Tumor, What Imaging modality? Retina Today. 2016 July/August.
  • Fuller TS, Rizwan A, Shields CL. Optical Coherence Tomography of Cavitary Retinoblastoma. JAMA Ophthalmology. 2016 May; 134(5).
  • Shields CL, Say EA, Fuller TS, Arora S, Samara WA, Shields JA. Retinal Astrocytic Hamartoma Arises in Nerve Fiber Layer and Shows “Moth-eaten” Optically Empty Spaces on Optical Coherence T Ophthalmology. 2016 August; 123(8):1809-16.
  • Shields CL, Say EA, Fuller TS, Arora S, Samara WA, Shields JA. Retinal Astrocytic Hamartoma Arises in Nerve Fiber Layer and Shows “Moth-eaten” Optically Empty Spaces on Optical Coherence Tomography. Poster Presentation at AAO 2016.
  • Williams PD, Chong D, Fuller TS, Callanan D. Non-infectious Vitritis After Intravitreal Injection of Anti-VEGF Agents: Variations in Rates and Presentation by M Retina. 2016 May;36(5):909- 13.
  • Blieden LS, Chuang AZ, Baker LA, Bell NP, Fuller TS, Mankiewicz KA, Feldman RM. Optimal Number of Angle Images for Calculating Anterior Angle Volume and Iris Volume Measurements. Invest Ophthalmol Vis Sci., 2015 May 1;56(5):2842-7.
  • Optimal Number of Scans for Calculating Anterior Angle Volume and Iris Volume Measurements. Poster presented at the American Glaucoma Society Annual Meeting. Washington D.C. February 2014.
  • Ocular Oncology Update, Texas Health Resources Presbyterian Dallas Spring Symposium, 2017.
  • Diagnosis, Treatment and Management of Uveal Melanoma, lecture to residents, UT Southwestern Medical School Department of Ophthalmology, Fall 2016 – present.
  • Adjunct Assistant Professor in Ophthalmology — UT Southwestern Medical Center, August 2022 – present.
  • Petit Goave, Haiti, January 2015. Spent one week along with several other doctors at the Methodist Eye Clinic screening, evaluating and treating approximately 1,000 patients for various ophthalmological conditions.
  • Casa Maria free clinic, Houston, Texas, 2006 – 2007. Interpreted for doctors at clinic.
  • Free Clinic of Our Towns, Davidson, North Carolina, 2003 – 2005. Interpreted for doctors, nurses, and staff at clinic.
  • North Dallas Shared Ministries free clinic, Dallas, Texas, 2003 – 2006. Interpreted for doctors, nurses, and staff at clinic.